IDH2 mutations can be detected using various molecular diagnostic techniques, such as next-generation sequencing (NGS), polymerase chain reaction (PCR)-based methods, and Sanger sequencing. These techniques allow for the precise identification of specific mutations within the IDH2 gene, which is critical for guiding targeted therapy.
